Exicure, Inc.
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
Last updated:
Abstract:
Aspects of the invention relate to spherical nucleic acid-based constructs and related methods and compositions thereof. The compositions of the invention are useful for activating agonists of nucleic acid interacting complexes, such as TLRs, stimulating an immune response, and treating diseases such as infectious disease, cancer, allergies, allergic diseases, and autoimmune disease.
Status:
Grant
Type:
Utility
Filling date:
15 May 2018
Issue date:
17 Nov 2020